本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

40.00
-0.3500-0.87%
盘后40.340.3386+0.85%19:06 EDT
成交量:82.46万
成交额:3,330.21万
市值:23.17亿
市盈率:3.49
高:41.19
开:40.70
低:39.96
收:40.35
数据加载中...
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]